Skip to main content
Right Decisions for Health and Care
Right Decisions for Health and Care
Search for toolkits, guidelines and other information:
Search 'Polypharmacy guidance: realistic prescribing'...
Menu
All resources
Organisations
Learning & support
How to deliver RDS tools
Feedback
Right Decisions
Polypharmacy guidance: realistic prescribing
Back
Medicines
By Medicine
Announcements and latest updates
test announcement
Print this page
By Medicine
Polypharmacy guidance: realistic prescribing
Scottish Government Effective Prescribing & Therapeutics Division
ACEI/ARBs
Alpha-blockers
Antianginals
Antiarrhythmic - Amiodarone
Antibacterials (oral), Nitrofurantoin
Anticoagulants
Antidementia drugs
Antidiabetics
Antiepileptics
Antifungals
Antihistamines
Antihistamines (1st generation)
Antimuscarinics
Antiplatelets
Antipsychotics
Antispasmodics
Beta-blockers
Bisphosphonates
BP lowering drugs
CCBs
Cytotoxics
Digoxin
Diuretics
DMARDs
Drops, sprays, ointments
Female Hormones
Finasteride
H2 Blockers
Hypnotics and anxiolytics
Inhalers
Laxatives
Metformin, sulfonylureas, glitazones
Metoclopramide
NSAIDs
Opioids
Paracetamol
Peripheral vasodilators
Potassium
PPI's
Quinine
Skeletal muscle relaxants
Spironolactone
Statins
Steroids
Supplements
Theophylline
Tricyclic antidepressants
Back to the top
Polypharmacy guidance: realistic prescribing
